Para Infectious Guillain–Barre Syndrome (GBS) in Covid-19 – A Case Report

Abstract

Covid-19 is a disease caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). SARS-CoV-2 which affects respiratory, gastrointestinal and neurological systems. It not only causes atypical pneumonia with acute respiratory distress syndrome (ARDS), but also, acute cardiac damage, acute renal failure and gastrointestinal complications.1 It is a disorder that not only presents with fever and respiratory symptoms but can involve the nervous system with varied presentations in form of cerebrovascular accident, loss of taste, loss of smell, myelopathy, neuropathy, meningitis and encephalitis.2 Some cases of Guillain–Barre syndrome (GBS) associated with SARS-CoV-2 have been reported in the literature. GBS is acute immune mediated inflammatory polyradiculopathy.3 GBS presents as limb weakness or cranial nerve weakness, loss of deep tendon reflex, autonomic dysfunction due to peripheral nerve demyelination and sensory root demyelination.